Power3 Medical Products Files Utility Patent Application On Discovery that Distinguishes Between Parkinson’s And ALS; New Power3 Medical Study Reveals Serum Biomarkers For Early ID Of Parkinson’s And ALS

HOUSTON--(BUSINESS WIRE)--Sept. 20, 2006--Power3 Medical Products, Inc. (OTC: PWRM), announced today that it has filed for a utility patent that encompasses multiple blood serum protein biomarkers useful in distinguishing patients with Parkinson’s disease and ALS (Lou Gehrig’s disease). Power3 (www.Power3Medical.com) is a leading proteomics company that develops proteomic testing and biomarker discovery for early detection, monitoring and staging of diseases including breast cancer, Alzheimer’s, Parkinson’s and ALS.